ClinicalTrials.Veeva

Menu

Epidemiological Study in Subjects With Vulvovaginal Candidiases

D

Dr. Santiago Palacios

Status

Completed

Conditions

Vulvovaginal Candidiases

Study type

Observational

Funder types

Other

Identifiers

NCT03064789
IP-01-2016

Details and patient eligibility

About

Epidemiological study about the clinical and microbiological progress in subjects under treatment for a severe vulvovaginal candidiases episody

Enrollment

43 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Sexually active women between 18 and 50 years of age at time of screening
  • With diagnosis and symptomatology of VVC

Exclusion criteria

  • Pregnant women
  • Diabetes Mellitus
  • Women witihin three months after a delivery or misbirth
  • Women with vaginal or genital infection symptomatology other than candidiases that needs antibiotic treatment
  • Vaginal probiotics use within last three months
  • Undiagnosed abnormal genital hemorrhage

Trial design

43 participants in 1 patient group

Women with candidiases infection
Description:
Women that are prescribed treatment with clotrimazole: 500 mg. and probiotics (routine clinical practice)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems